Finanças

Notícias Discussões Sinais técnicos Previsão Sazonais

Despesas operacionais (excl. CPV) de Aligos Therapeutics, Inc..

Dados anuais

2019

2020

2021

2022

2023

TTM

‪‪−140,00 M‬‬

‪‪−105,00 M‬‬

‪‪−70,00 M‬‬

‪‪−35,00 M‬‬

‪0,00‬

Período

Valor

Variação

Variação %

TTM

‪‪−97,86 M‬‬

+‪‪2,03 M‬‬

+‪2,03‬%

2023

‪‪−99,89 M‬‬

+‪‪7,92 M‬‬

+‪7,35‬%

2022

‪‪−107,81 M‬‬

+‪‪21,09 M‬‬

+‪16,36‬%

2021

‪‪−128,90 M‬‬

‪‪−34,39 M‬‬

‪−36,39‬%

2020

‪‪−94,51 M‬‬

‪‪−42,77 M‬‬

‪−82,65‬%

2019

‪‪−51,74 M‬‬

‪‪−39,37 M‬‬

‪−318,30‬%

Dados trimestrais

Q3 '20

Q4 '20

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

Q3 '24

‪‪−28,00 M‬‬

‪‪−21,00 M‬‬

‪‪−14,00 M‬‬

‪‪−7,00 M‬‬

‪0,00‬

Período

Valor

Variação

Variação %

Q3 '24

‪‪−20,73 M‬‬

+‪‪6,13 M‬‬

+‪22,83‬%

Q2 '24

‪‪−26,86 M‬‬

‪‪−4,51 M‬‬

‪−20,16‬%

Q1 '24

‪‪−22,36 M‬‬

+‪‪5,54 M‬‬

+‪19,87‬%

Q4 '23

‪‪−27,90 M‬‬

‪‪−6,27 M‬‬

‪−29,01‬%

Q3 '23

‪‪−21,63 M‬‬

+‪‪3,63 M‬‬

+‪14,37‬%

Q2 '23

‪‪−25,26 M‬‬

+‪‪539,00 K‬‬

+‪2,09‬%

Q1 '23

‪‪−25,80 M‬‬

‪‪−475,00 K‬‬

‪−1,88‬%

Q4 '22

‪‪−25,32 M‬‬

‪‪−3,17 M‬‬

‪−14,33‬%

Q3 '22

Q2 '22

Q1 '22

Q4 '21

Q3 '21

Q2 '21

Q1 '21

Q4 '20

Q3 '20